ORKA compared with SYRE: revenue, margins and what each company keeps, and the suppliers and customers both name

ORKAOruka Therapeutics, Inc.

Mkt capRevenueRevenue

SYRESpyre Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ORKAOruka Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ORKA: latest quarter not drawable. SYRE: latest quarter not drawable.Method ›

Price

rebased to 0%

ORKA, solidSYRE, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ORKA 0

None

Shared 0

No disclosed counterparties: ORKA.

Only SYRE 5

—WuXi Biologics (Hong Kong)unlistedsupplier

—Paragonunlistedsupplier

—WuXi Biologicsunlistedsupplier

—Equiniti Trust Company LLC (f/k/a American Stock Transfer & Trust Company LLC)unlistedsupplier

1 more · SYRE chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ORKAOruka Therapeutics, Inc.

96.24▼−0.42%· post 98.76

Mkt cap$6.4B

SYRESpyre Therapeutics, Inc.

96.44▼−2.55%

ClosedOct 30 '26

Mkt cap$8.5B

Compare

ClosedOct 30 '26

ORKAOruka Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.

96.24▼−0.42%post 98.76

Price

96.44▼−2.55%

$6.4B

Mkt cap

$8.5B

ORKA96.24▼−0.42%vsSYRE96.44▼−2.55%ClosedOct 30 '26